COMBINATION THERAPY WITH SPARSENTAN AND A SGLT2 INHIBITOR FOR TREATING KIDNEY DISEASES OR… Application WO-2024073672-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2024